← Back to stories

Neurotechnology startups exploit human brain cells for AI data centers amid ethical and systemic risks

Mainstream coverage frames this as a breakthrough in AI hardware, obscuring the extractive labor model of commodifying neural tissue, the colonial legacy of brain research, and the unaddressed risks of biohybrid systems. The narrative ignores how this technology replicates capitalist exploitation of biological materials while masking its environmental and ethical debt. Without systemic scrutiny, the focus on 'efficiency' distracts from the power asymmetries in who controls such innovations and who bears their costs.

⚡ Power-Knowledge Audit

The narrative is produced by New Scientist, a publication historically aligned with techno-optimist framings that privilege Western scientific institutions and venture capital interests. The framing serves the agenda of Cortical Labs and its investors by legitimizing the extraction and commercialization of human neural tissue, while obscuring the labor of underpaid researchers and the ethical dilemmas of treating brain cells as proprietary assets. This aligns with broader patterns of 'neoliberal technosolutionism,' where complex biological systems are reduced to marketable commodities.

📐 Analysis Dimensions

Eight knowledge lenses applied to this story by the Cogniosynthetic Corrective Engine.

🔍 What's Missing

The original framing omits the colonial histories of brain research, particularly the exploitation of marginalized populations in neuroscience; the lack of informed consent frameworks for using human neural tissue; the environmental costs of data center infrastructure; and the erasure of indigenous and non-Western perspectives on the sacredness of human cognition. It also ignores the precarious labor conditions of the workers handling these materials and the long-term risks of biohybrid AI systems.

An ACST audit of what the original framing omits. Eligible for cross-reference under the ACST vocabulary.

🛠️ Solution Pathways

  1. 01

    Establish Global Bioethics Frameworks for Neural Tissue

    Create legally binding treaties under the WHO to classify human neural tissue as a protected entity, requiring informed consent, traceability, and compensation for donors. These frameworks should be co-designed with Indigenous leaders, disability rights activists, and Global South representatives to avoid repeating colonial-era abuses. Include provisions for the ethical sourcing of neurons, akin to the Nagoya Protocol for genetic resources.

  2. 02

    Decentralize Neurotechnology Governance

    Shift oversight from corporate-controlled ethics boards to independent, multi-stakeholder bodies that include marginalized communities, bioethicists, and spiritual leaders. Implement participatory technology assessment models, such as citizen juries, to evaluate the societal impacts of biohybrid AI before commercialization. This mirrors the precautionary principle applied in environmental law.

  3. 03

    Invest in Non-Extractive AI Alternatives

    Redirect funding toward neuromorphic computing using synthetic materials, which can achieve similar efficiency without ethical violations. Support research into 'green AI' that minimizes energy and resource use, addressing both environmental and ethical concerns. Public institutions should prioritize these alternatives over biohybrid systems until robust safeguards are in place.

  4. 04

    Center Indigenous and Local Knowledge in Tech Development

    Mandate collaboration with Indigenous communities in all neurotechnology projects, ensuring their knowledge systems inform design and ethics. Establish Indigenous-led biobanks for neural tissue, where consent is tied to cultural protocols rather than Western legal frameworks. This approach aligns with the UN Declaration on the Rights of Indigenous Peoples and decolonial science practices.

🧬 Integrated Synthesis

The Cortical Labs project exemplifies the convergence of neoliberal technosolutionism and colonial extractivism, where the commodification of human neural tissue is framed as innovation while its ethical and ecological debts are deferred. Historically, this mirrors the exploitation of marginalized bodies in neuroscience, from the Tuskegee experiments to the industrialization of agriculture, where life is reduced to inputs for profit. Cross-culturally, the technology clashes with Indigenous epistemologies that view the brain as sacred and interconnected, not a modular component for AI. Scientifically, the project's premature scaling ignores the instability of biological systems and the lack of consent frameworks, risking a new era of bio-colonialism. Without systemic intervention—through global bioethics treaties, decentralized governance, and investment in non-extractive alternatives—this technology will deepen power asymmetries, exploit marginalized labor, and normalize the treatment of sentient matter as disposable infrastructure. The solution lies not in prohibiting innovation but in redefining progress through collective, decolonial, and ecologically accountable frameworks.

🔗